Clinical Trial Update: Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF [Phase 2]

View source ↗

Summary

A Phase 2 trial tested halting growth of liver tumors from uveal melanoma by hepatic artery closure after GM-CSF injection; the study has completed with posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases
• Uveal Melanoma

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Uveal Melanoma, Liver Metastases | Phase 2 | Status: COMPLETED | Results posted: 2015-06-01